Highlights iNtRON Biotechnology, Inc.

Equities

A048530

KR7048530000

End-of-day quote Korea S.E. Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
6,230 ^KRW	+2.13%		+1.80%	-29.04%

03-13	INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-15	Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer	02-15	CI
INtRON Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Basilea Pharmaceutica Signs Evaluation License, Option Deal With Korea's iNtRON	31/10/23	MT
INtRON Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.	03/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.	03/08/23	CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on December 2, 2022, has expired with 324,118 shares, representing 0.97% for KRW 2,997.54 million.	02/08/23	CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on December 2, 2022, has expired with	02/08/23	CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on September 20, 2022, has expired with 294,186 shares, representing 0.87% for KRW 2,998.6 million.	02/08/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.	06/07/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.	06/07/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.	06/07/23	CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.	06/07/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights iNtRON Biotechnology, Inc.

Equities

A048530

KR7048530000

Highlights

Filters